Medical Affairs
Bring scientific thinking into sharper strategic focus
Landscape Assessment
Build a clear, structured understanding of the clinical landscape and how it is evolving.
Medical Strategy
Translate clinical understanding into clear, strategically aligned direction.
KOL Engagement Planning
Define how to engage key experts in ways that generate meaningful strategic input.
Early-Stage Asset Strategy
Shape early-stage assets to maximise future differentiation, value, and probability of success.
Contact one of our Medical experts today
Clinical Landscape Assessment
In complex therapy areas, data, guidelines, and treatment dynamics are constantly shifting, making it difficult to see what truly matters.
We bring these elements together into a coherent view, identifying the implications for strategy and decision-making.
Key areas of focus:
- Clinical data interpretation and synthesis
- Treatment pathway and line of therapy mapping
- Guideline and standard of care evolution
- Competitor clinical positioning and differentiation
- Identification of clinical gaps and unmet need
Giving you clarity on what matters within the clinical landscape and how it should shape your strategy.
Medical Strategy
Medical strategy plays a critical role in shaping how evidence is generated, communicated, and understood across the organisation.
We ensure medical thinking is fully integrated into broader strategic decisions, strengthening the overall direction.
Key areas of focus:
- Medical input into brand and portfolio strategy
- Evidence generation and strategic alignment
- Scientific narrative and positioning
- Cross-functional integration with commercial and insight
- Strategic support for key decision points
Ensuring medical thinking is embedded in the decisions that define strategy and long-term direction.
KOL Engagement Planning
KOL engagement is most valuable when it goes beyond information exchange to shape thinking, challenge assumptions, and inform decisions.
We design engagement approaches that are focused, purposeful, and aligned to your strategic priorities.
Key areas of focus:
- KOL identification and prioritisation
- Aligning key questions and decisions
- Advisory board and interaction design
- Integration with evidence and brand strategy
- Planning of high-impact expert moments
Focusing expert engagement where it will have the greatest impact on thinking, decisions, and strategy.
Early-Stage Asset Strategy
Before Phase 3, critical decisions around value proposition, positioning, and development strategy can define long-term success.
We bring early clarity to how assets should be developed, differentiated, and positioned to succeed in future markets.
Key areas of focus:
- Early value proposition and differentiation strategy
- Target patient segment and positioning definition
- Clinical development optimisation and trade-offs
- Identification of future market opportunities and risks
- Market shaping and evidence planning considerations
- Clinical, commercial, and competitive perspectives
Shaping assets early to strengthen differentiation, guide development decisions, and maximise future impact.